AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26

Authors: Hanks, GE Hanlon, AL Horwitz, EM
Citation: Ge. Hanks et al., Evidence for cure of 'young' men with prostate cancer, ONCOLOGY-NY, 15(5), 2001, pp. 563-567

Authors: Sasson, AR Pingpank, JF Wetherington, RW Hanlon, AL Ridge, JA
Citation: Ar. Sasson et al., Incidental parathyroidectomy during thyroid surgery does not cause transient symptomatic hypocalcemia, ARCH OTOLAR, 127(3), 2001, pp. 304-308

Authors: Hanlon, AL Pinover, WH Horwitz, EM Hanks, GE
Citation: Al. Hanlon et al., Patterns and fate of PSA bouncing following 3D-CRT, INT J RAD O, 50(4), 2001, pp. 845-849

Authors: Hanlon, AL Bruner, DW Peter, R Hanks, GE
Citation: Al. Hanlon et al., Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: Comparing late bowel and bladder quality of life symptoms to that of the normal population, INT J RAD O, 49(1), 2001, pp. 51-59

Authors: Movsas, B Chapman, JD Hanlon, AL Horwitz, EM Pinover, WH Greenberg, RE Stobbe, C Hanks, GE
Citation: B. Movsas et al., Hypoxia in human prostate carcinoma - An Eppendorf Po-2 study, AM J CL ONC, 24(5), 2001, pp. 458-461

Authors: Jordan, JJ Hanlon, AL Al-Saleem, TI Greenberg, RE Tricoli, JV
Citation: Jj. Jordan et al., Loss of the short arm of the Y chromosome in human prostate carcinoma, CANC GENET, 124(2), 2001, pp. 122-126

Authors: Winter, DL Hanlon, AL Raysor, SL Watkins-Bruner, D Pinover, WH Hanks, GE Tricoli, JV
Citation: Dl. Winter et al., Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer, UROLOGY, 58(4), 2001, pp. 614-618

Authors: Cvetkovic, D Movsas, B Dicker, AP Hanlon, AL Greenberg, RE Chapman, JD Hanks, GE Tricoli, JV
Citation: D. Cvetkovic et al., Increased hypoxia correlates with increased expression of the angiogenesismarker vascular endothelial growth factor in human prostate cancer, UROLOGY, 57(4), 2001, pp. 821-825

Authors: Horwitz, EM Hanlon, AL Pinover, WH Anderson, PR Hanks, GE
Citation: Em. Horwitz et al., Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques, CANCER, 92(5), 2001, pp. 1281-1287

Authors: Sasson, AR Fowble, B Hanlon, AL Torosian, MH Freedman, G Boraas, M Sigurdson, ER Hoffman, JP Eisenberg, BL Patchefsky, A
Citation: Ar. Sasson et al., Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservativesurgery and radiation, CANCER, 91(10), 2001, pp. 1862-1869

Authors: Hanlon, AL Hanks, GE
Citation: Al. Hanlon et Ge. Hanks, Failure pattern implications following external beam irradiation of prostate cancer: Long-term follow-up and indications of cure, CANCER J, 6, 2000, pp. S193-S197

Authors: Hanlon, AL Pinover, WH Horwitz, EM Hanks, GE
Citation: Al. Hanlon et al., Regarding Vicini et al., IJROBP 1999;45 : 553-561, INT J RAD O, 47(5), 2000, pp. 1457-1457

Authors: Pinover, WH Hanlon, AL Horwiltz, EM Hanks, GE
Citation: Wh. Pinover et al., Defining the appropriate radiation dose for pretreatment PSA <= 10 ng/mL prostate cancer, INT J RAD O, 47(3), 2000, pp. 649-654

Authors: Hanks, GE Hanlon, AL Pinover, WH Horwitz, EM Price, RA Schultheiss, T
Citation: Ge. Hanks et al., Dose selection for prostate cancer patients based on dose comparison and dose response studies, INT J RAD O, 46(4), 2000, pp. 823-832

Authors: Hanlon, AL Hanks, GE
Citation: Al. Hanlon et Ge. Hanks, Scrutiny of the astro consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness, INT J RAD O, 46(3), 2000, pp. 559-566

Authors: Hanlon, AL Hanks, GE
Citation: Al. Hanlon et Ge. Hanks, Failure patterns and hazard rates for failure suggest the cure of prostatecancer by external beam radiation, UROLOGY, 55(5), 2000, pp. 725-729

Authors: Movsas, B Chapman, JD Greenberg, RE Hanlon, AL Horwitz, EM Pinover, WH Stobbe, C Hanks, GE
Citation: B. Movsas et al., Increasing levels of hypoxia in prostate carcinoma correlate significantlywith increasing clinical stage and patient age - An Eppendorf pO(2) study, CANCER, 89(9), 2000, pp. 2018-2024

Authors: Anderson, PR Hanlon, AL Horwitz, E Pinover, W Hanks, GE
Citation: Pr. Anderson et al., Outcome and predictive factors for patients with Gleason score 7 prostate carcinoma treated with three-dimensional conformal external beam radiation therapy, CANCER, 89(12), 2000, pp. 2565-2569

Authors: Hanks, GE Hanlon, AL Pinover, WH Horwitz, EM Schultheiss, TE
Citation: Ge. Hanks et al., Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy, CA J SCI AM, 5(3), 1999, pp. 152-158

Authors: Horwitz, EM Hanlon, AL Pinover, WH Hanks, GE
Citation: Em. Horwitz et al., Is there a role for short-term hormone use in the treatment of nonmetastatic prostate cancer?, RADIAT ON I, 7(4), 1999, pp. 249-259

Authors: Algan, O Pinover, WH Hanlon, AL Al-Saleem, TI Hanks, GE
Citation: O. Algan et al., Is there a subset of patients with PSA >= 20 ng/ml who do well after conformal beam radiotherapy?, RADIAT ON I, 7(2), 1999, pp. 106-110

Authors: Horwitz, EM Hanlon, AL Pinover, WH Hanks, GE
Citation: Em. Horwitz et al., The cost effectiveness of 3D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer, INT J RAD O, 45(5), 1999, pp. 1219-1225

Authors: Herold, DM Hanlon, AL Hanks, GE
Citation: Dm. Herold et al., Diabetes mellitus: A predictor for late radiation morbidity, INT J RAD O, 43(3), 1999, pp. 475-479

Authors: Tricoli, JV Winter, DL Hanlon, AL Raysor, SL Watkins-Bruner, D Pinover, WH Hanks, GE
Citation: Jv. Tricoli et al., Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer, UROLOGY, 54(1), 1999, pp. 178-182

Authors: Movsas, B Chapman, JD Horwitz, EM Pinover, WH Greenberg, RE Hanlon, AL Iyer, R Hanks, GE
Citation: B. Movsas et al., Hypoxic regions exist in human prostate carcinoma, UROLOGY, 53(1), 1999, pp. 11-18
Risultati: 1-25 | 26-26